Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
Synopsis: At the intersection of personal mission and biotech leadership, Rahul Chaturvedi sits down with Catherine Owen Adams, CEO of Acadia Pharmaceuticals, for a deeply personal and strategically...
13 Touko 33min
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Synopsis: This episode is proudly sponsored by Quartzy. At a time when biotech innovation is being reshaped by science, capital, and global dynamics, Alok Tayi sits down with Barry Quart, CEO of Co...
16 Huhti 23min
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Synopsis: Addiction is often misunderstood as a failure of willpower—but emerging science increasingly shows it may be deeply rooted in biology. In this episode of Biotech 2050, recorded during JPM...
6 Maalis 14min
Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders
Synopsis: This episode is proudly sponsored by Quartzy. Physician-scientist, biotech founder, and leadership advocate Sheila Gujrathi, MD joins Rahul Chaturvedi on the Biotech 2050 Podcast for a po...
5 Maalis 39min
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could ...
11 Helmi 25min
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, to Biotech 2050 for a powerful conversation at the intersection of personal mission, platform biology, and...
10 Helmi 26min
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
Synopsis: From managing a theme park in Canada to leading the U.S. business of one of the world’s largest privately held pharma companies, Brian Hilberdink’s journey is anything but conventional. Li...
28 Tammi 21min
Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
Synopsis: Fresh from the JPM 2026 in San Francisco, Alok Tayi welcomes Johan Luthman, Executive Vice President of R&D at Lundbeck, for a sweeping, deeply personal conversation on the future of neuro...
27 Tammi 31min
